SCIB — SciBase Holding AB (publ) Share News
0.000.00%
- SEK330.28m
- SEK259.02m
- SEK40.46m
Brief: Scibase Holding Q1 Net Sales At SEK 4.3 Mln
Brief: SciBase: Patent Application Granted By EPO In Europe
Brief: Scibase Barrier Technology Part Of Immunodermatology Project
Brief: Scibase Gets Electrode Order Worth EUR 60,000
Brief: Scibase Holding Q4 Loss After Tax At SEK 13.9 Mln
Brief: SciBase Holding Receives Order Of Ten Additional Nevisense Systems
Brief: Scibase Q3 Loss At SEK 8.6 Mln
Brief: Scibase Holding Q2 Loss After Tax Widens To SEK 11.2 Million
Brief: SciBase Raises SEK 71.2 Mln Through Two Directed Issues
Brief: Scibase Holding AB (Publ) - Q1 Loss After Tax Amounted To Tsek 8,153
Brief: SciBase Gets European MDR Certification
Brief: SciBase Study Shows Nevisense Potential For Assessment Of Skin Barrier
Brief: SciBase: Study Supports Use Of Nevisense Within New Non-Melanoma Skin Cancer Application
Brief: Scibase Q3 Loss Narrwos To SEK 7.4 Mln
Brief: SciBase Holding: Positive Step For US reimbursement Of Nevisense
Brief: Scibase Holding: Outcome Of Exercise Of Warrants Of Series TO1
Brief: SciBase Holding: Exercise Price For Exercise Of Warrants Determined To SEK 1.75
Brief: SciBase Holding Updates On New Clinical Studies Of Nevisense
Brief: SciBase Holding Q2 Loss After Tax Narrows To SEK 8.9 Mln